| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |